Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs

The Supreme Court agreed to consider a dispute between Novartis and Amgen that could determine how soon cheaper, copycat versions of biotechnology drugs can be sold to consumers.

from WSJ.com: US Business http://ift.tt/2iREtb8
via IFTTT